- Home
- BLIV vs MLEC Comparison
BLIV vs MLEC Comparison
Compare BLIV & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIV
- MLEC
- Stock Information
- Founded
- BLIV 2014
- MLEC 2008
- Country
- BLIV Singapore
- MLEC United Kingdom
- Employees
- BLIV N/A
- MLEC N/A
- Industry
- BLIV
- MLEC Blank Checks
- Sector
- BLIV
- MLEC Finance
- Exchange
- BLIV NYSE
- MLEC Nasdaq
- Market Cap
- BLIV 39.8M
- MLEC 36.0M
- IPO Year
- BLIV 2025
- MLEC N/A
- Fundamental
- Price
- BLIV $3.79
- MLEC $6.77
- Analyst Decision
- BLIV
- MLEC
- Analyst Count
- BLIV 0
- MLEC 0
- Target Price
- BLIV N/A
- MLEC N/A
- AVG Volume (30 Days)
- BLIV 68.2K
- MLEC 2.6K
- Earning Date
- BLIV 01-01-0001
- MLEC 07-01-2025
- Dividend Yield
- BLIV N/A
- MLEC N/A
- EPS Growth
- BLIV N/A
- MLEC N/A
- EPS
- BLIV N/A
- MLEC N/A
- Revenue
- BLIV $1,355,200.00
- MLEC N/A
- Revenue This Year
- BLIV N/A
- MLEC $20.42
- Revenue Next Year
- BLIV N/A
- MLEC $30.00
- P/E Ratio
- BLIV N/A
- MLEC N/A
- Revenue Growth
- BLIV N/A
- MLEC 170.36
- 52 Week Low
- BLIV $2.69
- MLEC $5.30
- 52 Week High
- BLIV $6.40
- MLEC $11.60
- Technical
- Relative Strength Index (RSI)
- BLIV N/A
- MLEC 35.14
- Support Level
- BLIV N/A
- MLEC $5.63
- Resistance Level
- BLIV N/A
- MLEC $8.00
- Average True Range (ATR)
- BLIV 0.00
- MLEC 0.76
- MACD
- BLIV 0.00
- MLEC -0.13
- Stochastic Oscillator
- BLIV 0.00
- MLEC 1.42
About MLEC Moolec Science SA
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.